PATANASE (ALCON LABORATORIES, INC.)
Welcome to the PulseAid listing for the PATANASE drug offered from ALCON LABORATORIES, INC.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ALCON LABORATORIES, INC. |
NON-PROPRIETARY NAME: | olopatadine hydrochloride |
SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-04-28 |
END MARKETING DATE: | 0000-00-00 |
PATANASE HUMAN PRESCRIPTION DRUG Details:
Item Description | PATANASE from ALCON LABORATORIES, INC. |
LABELER NAME: | ALCON LABORATORIES, INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 600(ug/1) |
START MARKETING DATE: | 2008-04-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0065-0332_4ce345c6-362e-d0e4-5792-2d0f5ccc9bfd |
PRODUCT NDC: | 0065-0332 |
APPLICATION NUMBER: | NDA021861 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: